117465-34-6

Basic information

• Product Name: 2-bromo-1-(4-bromophenyl)ethanol
• Synonyms: 2-bromo-1-(4-bromophenyl)ethanol
• CAS NO: 117465-34-6
• Molecular Weight: 279.959
• Mol File: 117465-34-6.mol
• Article Data: 26

Chemical Properties

• CAS DataBase Reference: 2-bromo-1-(4-bromophenyl)ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-1-(4-bromophenyl)ethanol(117465-34-6)
• EPA Substance Registry System: 2-bromo-1-(4-bromophenyl)ethanol(117465-34-6)

Safety Data

• Hazardous Substances Data: 117465-34-6(Hazardous Substances Data)

Upstream product

• 99-73-0 para-bromophenacyl bromide 
• 2039-82-9 1-bromo-4-ethenyl-benzene 
• 33458-10-5 1-bromo-4-(1,2-dibromoethyl)benzene 

Downstream Products

• 109275-40-3 Acetic acid (R)-2-bromo-1-(4-bromo-phenyl)-ethyl ester 
• 117340-82-6 (S)-1-acetoxy-2-bromo-1-(4-bromophenyl)ethane 
• 53250-08-1 1-(4-bromophenyl)-2-(dimethylamino)ethanone 
• 71559-14-3 2-azido-1-(4-bromophenyl)ethanone 
• 100306-24-9 (S)-2-bromo-1-(4-bromophenyl)ethanol 
• 96855-38-8 (R)?2?bromo?1?(4′?bromophenyl)ethanol 
• 148684-05-3 2-(4-bromophenyl)oxirane 
• 31377-97-6 1-(4-bromophenyl)-2-tosylethanone 
• 115665-68-4 (E)-1-bromo-4-(2-bromovinyl)benzene 
• 115665-77-5 (Z)-1-[2-bromovinyl]-4-bromobenzene 
• 1411789-91-7 C₂₀H₂₃Br₃O 
• 1411789-55-3 4,4'-(oxybis(2-bromoethane-1,1-diyl))bis(bromobenzene) 
• 62566-68-1 (R)-2-(4-bromophenyl)oxirane 
• 99-73-0 para-bromophenacyl bromide 

Relevant articles and documents

Selective reductions with stable indium trihydride reagents

The carbene and tertiary phosphine adducts of indane, [InH3{CN(Mes)C2H2N(Mes)}] and [InH3{P(C6H11)3}] (Mes = 2,4,6-trimethylphenyl), have been used to reduce unsaturated organic functionalities. The success and selectivity of these reductions relative to those carried out with lighter group 13 hydride complexes is discussed. (C) 2000 Elsevier Science Ltd.

Structure-activity relationship studies for the development of inhibitors of murine adipose triglyceride lipase (ATGL)

High serum fatty acid (FA) levels are causally linked to the development of insulin resistance, which eventually progresses to type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) generalized in the term metabolic syndrome. Adipose triglyceride lipase (ATGL) is the initial enzyme in the hydrolysis of intracellular triacylglycerol (TG) stores, liberating fatty acids that are released from adipocytes into the circulation. Hence, ATGL-specific inhibitors have the potential to lower circulating FA concentrations, and counteract the development of insulin resistance and NAFLD. In this article, we report about structure–activity relationship (SAR) studies of small molecule inhibitors of murine ATGL which led to the development of Atglistatin. Atglistatin is a specific inhibitor of murine ATGL, which has proven useful for the validation of ATGL as a potential drug target.

Immobilization of Amano lipase from Pseudomonas fluorescens on silk fibroin spheres: an alternative protocol for the enantioselective synthesis of halohydrins

The search for a new, efficient, cheaper and sustainable matrix for lipase immobilization is a growing area in biotechnology. Amano lipase from Pseudomonas fluorescens was immobilized on silk fibroin spheres and used in the enzymatic kinetic resolution of halohydrins, to obtain optically active epoxides (up to 99% ee), important precursors in the synthesis of derivative antifungal azoles. This paper reinforces the versatility of silk fibroin as a support for heterogeneous catalysts.